Albuminuria as a marker of systemic congestion and a predictor of poor long-term prognosis in acute decompensated heart failure

Aim. To identify the relationship of different albuminuria levels with paraclinical signs of congestion on admission and discharge and with the prognosis of acute decompensated heart failure (ADHF).

Material and methods. Patients hospitalized with ADHF were included. Albuminu­ria level was assessed on admission and discharge. Patients were divided into groups according to albuminuria level (A1, A2, A3) according to KDIGO guidelines. Among the congestion parameters, the following were assessed: N-terminal pro-brain natriuretic peptide (NT-proBNP), lung ultrasound examination (BLUE protocol), venous congestion according to the VExUS ultrasound protocol (inferior vena cava, portal, hepatic and renal veins). The primary endpoint was a composite of all-cause death and rehospitalization for ADHF within 180 days of discharge.

Results. The final analysis included 180 patients. The prevalence of A1, A2 and A3 albuminuria at admission was 50%, 39%, 11%, respectively. A greater degree of albu­minuria was associated with worse renal function at admission and discharge. Pati­ents with increased albuminuria on admission had higher NT-proBNP and a greater number of B-lines on pulmonary ultrasound in on admission and discharge, and a higher degree of complex venous congestion and renal vein congestion on VExUS on admission. A3 albuminuria at admission and discharge was associated with an increased risk of poor long-term prognosis (hazard ratio (HR) 3,551; 95% confidence interval (CI) 1,593-7,914; p=0,002), (HR 4,362; 95% CI 1,623-11,726; p=0,004).

Conclusion. In patients with ADHF, the albuminuria level on admission is associated with the severity of congestion upon admission and discharge. A3 albuminuria at admission and at discharge is a predictor of long-term poor prognosis within 180 days after discharge.

1. Lahoz R, Fagan A, McSharry M, et al. Recurrent heart failure hospitalizations are associated with increased cardiovascular mortality in patients with heart failure in Clinical Practice Research Datalink. ESC Heart Fail. 2020;7(4):1688-99. doi:10.1002/ehf2.12727.

2. Kobalava ZD, Tolkacheva VV, Sarlykov BK, et al. Integral assessment of congestion in patients with acute decompensated heart failure. Russian Journal of Cardiology. 2022;27(2):4799. (In Russ.) doi:10.15829/1560-4071-2022-4799.

3. Khan MS, Shahid I, Anker SD, et al. Albuminuria and Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023;81(3):270-82. doi:10.1016/j.jacc.2022.10.028.

4. Souweine JS, Corbel A, Rigothier C, et al. Interest of albuminuria in nephrology, dia­betology and as a marker of cardiovascular risk. Ann Biol Clin (Paris). 2019;77(1):26-35. doi:10.1684/abc.2018.1402.

5. Boorsma EM, Ter Maaten JM, Damman K, et al. Albuminuria as a marker of systemic congestion in patients with heart failure. Eur Heart J. 2023;44(5):368-80. doi:10.1093/eurheartj/ehac528.

6. Aslanova R, Kobalava Zh, Safarova A, et al. Venous congestion on the VExUS scale in patients with decompensated heart failure. Klinicheskaya farmakologiya i terapiya = Clin Pharmacol Ther. 2022;31(2):27-31. (In Russ.) doi:10.32756/0869-5490-2022-2-27-31.

7. Fiuzat M, Hamo CE, Butler J, et al. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;79(5):504-10. doi:10.1016/j.jacc.2021.11.033.

8. Odutayo A, Hsiao AJ, Emdin CA. Prevalence of Albuminuria in a General Population Cohort of Patients With Established Chronic Heart Failure. J Card Fail. 2016;22(1):33-7. doi:10.1016/j.cardfail.2015.10.009.

9. Statsenko ME, Fabritskaya SV, Ryndina YA. The role of obesity in renal damage in patients with chronic heart failure. Nephrology. 2020;24 (5):29-36. (In Russ.) doi:10.36485/1561-6274-2020-24-5-29-36.

10. Kang M, Kwon S, Lee J, et al. Albuminuria within the Normal Range Can Predict All-Cause Mortality and Cardiovascular Mortality. Kidney360. 2021;3(1):74-82. doi:10.34067/KID.0003912021.

11. Alshamari AHI, Kadhim RK, Al-Mohana SJA. The effect of serum uric acid concentration on the severity of chronic congestive heart failure. J Med Life. 2022;15(12):1569-72. doi:10.25122/jml-2022-0068.

12. Wallbach M, Valentova M, Schroeter MR, et al. Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation. Clin Res Cardiol. 2023;112(8):1087-95. doi:10.1007/s00392-023-02184-6.

13. Yunhong Wang, Xuemei Zhao, Mei Zhai, et al. Elevated urinary albumin concentration predicts worse clinical outcomes in hospitalized acute decompensated heart failure patients. ESC Heart Failure. 2021;8(4):3037-48. doi:10.1002/ehf2.13399.

14. Liang W, Liu Q, Wang QY, et al. Albuminuria and Dipstick Proteinuria for Predicting Mortality in Heart Failure: A Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021;8:665831. doi:10.3389/fcvm.2021.665831.